Conference Coverage
No clear winner for treating neuropathic pain
PHILADELPHIA – More head-to-head trials of treatments for neuropathic pain are needed.
News
New renal, CV disease indication sought for canagliflozin
Canagliflozin is currently indicated for patients with type 2 diabetes but may soon help treat those who also have chronic kidney disease.
From the Journals
Newer antihyperglycemic drugs have distinctive CV, kidney benefits
SGLT2 inhibitors and GLP-1 RAs have different effects on cardiovascular and kidney disease outcomes in patients with type 2 diabetes.
Sponsored Supplement
Headline can be up to 255 characters
From the Journals
Semaglutide plus SGLT2 inhibitors improves glycemic control in type 2 diabetes
Once-weekly treatment with the GLP-1 RA semaglutide helped most patients with type 2 diabetes on SGLT2 inhibitors meet their glycemic targets and...
From the Journals
Bariatric surgery leads to less improvement in black patients
Black patients who underwent bariatric surgery suffered more overall complications and reported a lower quality of life than white patients.
Conference Coverage
Lessons learned from the PCSK9 inhibitor trials
LOS ANGELES – The higher your risk, the greater your benefit from therapeutic intervention.
News
Tic disorders are associated with obesity and diabetes
Patients with Tourette syndrome or chronic tic disorder have a higher risk for metabolic and cardiovascular health problems, a population-based...
Conference Coverage
SGLT-2 inhibitors promising for heart failure prevention, not treatment
LOS ANGELES – The combination of heart failure and diabetes is particularly lethal.
Conference Coverage
Does reduced degradation of insulin by the liver cause type 2 diabetes?
LOS ANGELES – Hepatic insulin clearance is significantly lower in African Americans, compared with European Americans, a difference that may...
Conference Coverage
‘Payoff will be great’ if we can conquer childhood obesity, expert says
LOS ANGELES – Direct evidence of a link between obesity in youth and adult cardiovascular disease is beginning to emerge.
Conference Coverage
Real-world weight loss with meds approximates RCT results
NASHVILLE, TENN. – The real-world study saw more adverse events – but no attrition from side effects.
Conference Coverage
For weight-loss apps, the evidence base is still small
NASHVILLE – The most effective apps took advantage of gamification and other uniquely digital features.
Conference Coverage
Heavy drinkers have a harder time keeping the weight off
NASHVILLE – Teetotalers had the best luck maintaining weight loss, but the differences were small.
Conference Coverage
Study investigates statin-diabetes link
Complete results are expected by the end of 2019.
Conference Coverage
Should metabolic syndrome be renamed circadian syndrome?
Cluster of conditions “is now the main driver of the global chronic disease epidemic and its health burden,” expert says.
Conference Coverage
Diuretics linked to diabetic amputations in T2DM
BERLIN – An increase in lower extremity amputations was seen among patients with type 2 diabetes mellitus who were treated with diuretics.
From the Journals
Comorbid depression, anxiety linked to doubled risk of diabetes
“This study provides further support for the notion that depression with comorbid anxiety symptoms might represent a group...
Conference Coverage
Fewer hypos with CGM in routine pediatric T1DM care
BERLIN – In the first year after the initiation of continuous glucose monitoring, hypoglycemia episodes needing external help were significantly...
Conference Coverage
Nasal glucagon ‘viable alternative’ to intramuscular administration
BERLIN – Severe hypoglycemia was reversed successfully in all patients with type 1 diabetes mellitus given nasal glucagon.
Conference Coverage
DPP-4 drugs for diabetes may protect kidneys too
Mortality declined dramatically in patients with type 2 diabetes mellitus who took the medication over an average of 3 years.
Multimedia
Conference Coverage
-
-
-
-
-
